Showing 6261-6270 of 8582 results for "".
- Daniel Hopkins Named New CEO at AlumierMDhttps://practicaldermatology.com/news/daniel-hopkins-named-new-ceo-at-alumiermd/2461537/Daniel Hopkins is AlumierMD’s new Chief Executive Officer. With more than a decade of experience in the aesthetic sector, Mr. Hopkins is prepared to take AlumierMD's commitment to the global aesthetic community through its next exciting phase of growth. Mr. Hopkins
- Laura Geller Beauty's Signature Foundation Scores the National Psoriasis Foundation's Seal of Recognitionhttps://practicaldermatology.com/news/laura-geller-beautys-signature-foundation-scores-the-national-psoriasis-foundations-seal-of-recognition/2461533/The National Psoriasis Foundation granted its Seal of Recognition to Laura Geller Beauty's Signature Baked Balance-n-Brighten Color Correcting Foundation. This is the first makeup product to receive the National Psoriasis Foundation Seal of Recognition.
- CDC Report: Seven Percent of Adults and 11 Percent of Kids Had Eczema in 2021https://practicaldermatology.com/news/cdc-report-seven-percent-of-adults-and-11-percent-of-kids-had-eczema-in-2021/2461530/Slightly more than 7% of adults and nearly 11% of kids had eczema in 2021, according to two new reports in the CDC’s National Center for Health Statistics Data Brief. W
- Phase 2 Data: Jeuveau “Extra-Strength” Dose Produces Lasting Resultshttps://practicaldermatology.com/news/phase-2-data-jeuveau-extra-strength-dose-produces-lasting-results/2461528/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Study: 3D-printed Artificial Skin Can Be Used in Cosmetics and Drug Testinghttps://practicaldermatology.com/news/study-3d-printed-artificial-skin-can-be-used-in-cosmetics-and-drug-testing/2461525/Bioprinted artificial skin can be used in cosmetics and drug testing, a new study shows. For the study, researchers compared the conventional mimetic model based on manual pipetting with extrusion bioprinting, which “allows the in vitro reconstruction of a more relevant and repres
- Phase 2b Study: Arcutis' Roflumilast Cream Shows Sustained Efficacy in Adults with Chronic Plaque Psoriasishttps://practicaldermatology.com/news/pgase-2b-study-arcutis-roflumilast-cream-shows-sustained-efficacy-in-adults-with-chronic-plaque-psoriasis/2461513/Arcutis' roflumilast cream showed sustained efficacy with clearance for median of 10 Months in adults with chronic plaque psoriasis, according to an open label Phase 2 long-term safety study presented at the Winter Clinical dermatology meeting. Roflumilast cream
- First Patient Dosed in Phase II Clinical Trial of TLL018-205 for PsOhttps://practicaldermatology.com/news/first-patient-dosed-in-phase-ii-clinical-trial-of-tll018-205-for-pso/2461511/The first patient has been enrolled and dosed in a Phase II study evaluating the efficacy and safety of TLL-018 fpr moderate to severe plaque psoriasis. This study is sponsored by Hangzhou Highlightll Pharmaceutical Co., Ltd (Highlightll Pharmaceutical, USA). T
- La Roche Posay Celebrates Second Annual National HA Day on Jan. 21, 2023https://practicaldermatology.com/news/la-roche-posay-celebrates-second-annual-national-ha-day-on-jan-21-2023/2461510/La Roche-Posay is ringing in its second annual National Hyaluronic Acid Day on January 21st. To celebrate National Hyaluronic Acid Day, the brand is offering 20% off on orders of $65 or more on
- Sun Pharma Launches New AH-ha! It’s Acne Hormones Campaignhttps://practicaldermatology.com/news/sun-pharma-launches-new-ah-ha-its-acne-hormones-campaign/2461509/Sun Pharmaceutical Industries, Inc, is launching "AH-ha! It's Acne Hormones," an awareness campaign featuring Sandra Lee, MD (AKA TLC's "Dr. Pimple Popper"). The campaign is designed to spotlight hormones as
- Allergan Aesthetics Rolls Out Juvéderm Volux XChttps://practicaldermatology.com/news/allergan-aesthetics-rolls-out-juvederm-volux-xc/2461507/Allergan Aesthetics' Juvéderm Volux XC is now available at aesthetic practices nationwide. The filler is approved for patients older than 21 with moderate to severe loss of jawline definition. "With 40% of aesthetically-aware consumers considering tre